In the News
In the News
Changing behavior now, while the COVID19 increase is still manageable, is the best way for Colorado to avoid what’s happening in Houston, where ICUs have been overwhelmed, commented Jeffrey Morris, PhD.
Some challenges that confront scientists racing to develop COVID-19 treatments and vaccines resemble those faced in the past—with HIV, SARS, H1N1 and Ebola—while others are new. Susan Ellenberg, PhD, unpacks what we need to know about clinical trials during the current pandemic. Read the perspective piece in Clinical Trials.
Seeing groups hanging out together at concerts, bars and parties with few masks in sight, “It’s not surprising that people are spreading the virus,” Ebbing Lautenbach, MD, MPH, MSCE, told Philadelphia’s NBC10.
Declining COVID19 mortality rates shouldn’t be used to minimize the risk of the current surges, says Jeffrey Morris, PhD. He added, “Different parts of the country are experiencing very different things. It is kind of a paradox.”
Jeffrey Morris, PhD, commented on dire trends in Houston, based on analysis from our collaborative model with CHOP Policy Lab. Earlier, he had described ominous predictions on ABC Houston, saying the the area could be looking at a 10-fold increase.
For COVID-19 safety, we need to keep pursuing targeted mitigation strategies, commented Jeffrey Morris, PhD.
The pandemic presents an opportunity to rethink the way we do clinical research, write Stephen Kimmel, MD, MSCE, and collaborators.
M. Kit Delgado, MD, MS, comments on the safety of ride sharing services during the COVID-19 crisis.
Jordana Cohen, MD, MSCE, and co-investigator Julio Chirinos, MD, launched an international, multisite study to find out more about how ACE inhibitors and ARBS affect COVID-19. They are cautious about the drugs’ effects until they finish their research.
Peter Reese, MD, MSCE, and co-authors outline strategies to help save financially vulnerable safety-net hospitals that are on the front lines of the COVID-19 pandemic and at the risk of bankruptcy.
Pages
About Us
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics. LEARN MORE ABOUT US
© 2021 Trustees of the University of Pennsylvania. All rights reserved. | Disclaimer